Welcome to our dedicated page for Healthy Extracts SEC filings (Ticker: HYEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Healthy Extracts Inc. (HYEX) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including Forms 10-K, 10-Q, 8-K and ownership reports filed with the U.S. Securities and Exchange Commission. These documents offer detailed insight into the nutraceutical company’s operations, financial condition, risk factors and governance.
For a business that combines science-based nutraceuticals and proprietary oral delivery technologies, filings can be especially useful in understanding segment performance, capital structure and the impact of acquisitions. For example, an 8-K dated in 2025 describes the acquisition and subsequent merger structure involving Gummy USA LLC, the issuance of common stock representing a majority ownership stake to its founder, and the resulting change in control and board composition. Such filings explain how Gummy USA became a wholly owned subsidiary with a HACCP, GMP-certified and FDA-registered manufacturing facility.
Investors can use Healthy Extracts’ annual reports on Form 10-K to review comprehensive discussions of its nutraceutical platform, including BergametNA heart health products, Ultimate Brain Nutrients brain formulations, and exclusive delivery systems like Gelteq gel-packs and functional fiber drinking straws. Quarterly reports on Form 10-Q provide interim updates on net revenue trends, margins, subscription-based recurring revenue and liquidity.
Current reports on Form 8-K are particularly relevant for tracking material events such as mergers, changes in control, executive appointments, and key agreements. The 8-Ks referenced in the provided data detail Donald Swanson’s appointments as Chief Executive Officer and Chairman, anti-dilution rights associated with the Gummy USA transaction, and related governance changes.
Stock Titan enhances these filings with AI-powered summaries that highlight the most important points, helping readers quickly interpret complex disclosures without replacing the full text. Users can also review insider transaction reports on Form 4 when available to see how officers and directors transact in HYEX shares.
By combining real-time EDGAR updates with AI explanations, this page offers a focused way to analyze how Healthy Extracts’ SEC filings reflect its evolving nutraceutical portfolio, delivery technologies and corporate structure.
Healthy Extracts Inc. (HYEX) reported Q3 2025 results and closed a transformative equity transaction. Revenue for the quarter was $917,975 versus $744,916 a year ago, but the company posted a net loss of $395,394 after higher operating expenses. For the nine months, revenue reached $2,817,910 with a net loss of $727,133.
On July 19, 2025, HYEX agreed to acquire Gummy USA LLC and issued 13,075,920 common shares, representing 77.5% of the company after the deal. Following a rescission on September 26, 2025, the merger structure was revised and the shares were re‑issued effective October 1, 2025; the $23,536,656 related amount is presented as a long‑term investment pending consolidation analysis. Shares outstanding were 16,870,868 as of September 30, 2025.
Cash was $189,452, operating cash flow used was $202,634, and derivative liabilities were $557,997. Management disclosed substantial doubt about the company’s ability to continue as a going concern within one year.
Healthy Extracts Inc. completed the acquisition of Gummy USA LLC by merging it into a wholly owned subsidiary, HE Gummy USA, Inc. As consideration, the company issued 13,075,920 common shares to Gummy USA’s founder Donald Swanson, giving him 77.5% of the company’s outstanding common stock after the transaction and anti-dilution rights tied to 154,306 outstanding options and warrants.
The share issuance was an unregistered sale under Section 4(a)(2) of the Securities Act. Swanson was re-appointed as director, Chairman, and Chief Executive Officer, while Kevin “Duke” Pitts became President and Chief Operating Officer, and director William Bossung resigned. The company plans to file required Gummy USA financial statements and pro forma information in an amendment within 71 days.
Healthy Extracts Inc. reported a leadership change in its top executive roles. Effective September 16, 2025, Donald Swanson was appointed Chief Executive Officer, taking over the CEO position from Kevin “Duke” Pitts. At the same time, Kevin “Duke” Pitts was appointed President, replacing Donald Swanson in that role, and also became Chief Operating Officer. The company stated that there are no family relationships among its officers or directors.